2) Hepatitis B virus core antigen
乙型肝炎病毒核心抗原
1.
Construction and in vitro expression of bicistronic DNA vaccines containing hepatitis B virus core antigen and Flt3 ligand genes;
乙型肝炎病毒核心抗原及Flt3配体双表达核酸疫苗的构建与体外表达
3) Anti-HBc
乙型肝炎病毒核心抗体
1.
Preparation and application of discoloration dilution detecting anti-HBc antibody;
乙型肝炎病毒核心抗体变色稀释液的配制及应用
2.
2%) belonged to three typical HBV infected models:modelⅠwas HBsAg (+),HBeAg (+) and HBcAb (+);model Ⅱ was HBsAg (+),anti-HBe (+) and anti-HBc (+); model Ⅲ was HBsAg (+) and anti-HBc (+).
结果131例慢性乙型肝炎患者的HBV-M检测中,"大三阳","小三阳",乙型肝炎病毒表面抗原(HBsAg)阳性、乙型肝炎病毒核心抗体(抗-HBc)阳性三种典型感染模式为126例,占96。
4) HbcAg
乙型肝炎病毒核心抗原
1.
Objective To activate peripheral blood B lymphocytes by CpG-oligodeoxynucleotides(CpG-ODN) and load HBcAg 18-27 peptide to make them as antigen presenting cells(APC),then induce hepatitis B virus(HBV)-specific cytolytic T lymphocytes(CTL) from peripheral blood monocular cells(PBMC) of healthy human.
目的探讨负载乙型肝炎病毒核心抗原18-27(HBcAg 18-27)序列肽的活化B淋巴细胞诱导自体外周血单个核细胞(PBMC)产生HBcAg 18-27特异性细胞毒性T淋巴细胞(CTL)的能力。
5) anti-HBV agents
抗乙型肝炎病毒药物
1.
Advances in the research on non-nucleos(t)ide chemicals as anti-HBV agents;
非核苷类抗乙型肝炎病毒药物的研究进展
补充资料：丙型肝炎病毒抗原抗体
丙型肝炎病毒抗原抗体
antibody of hepatitis type C virus，anti－HCV
为丙型肝炎患者血清产生的针对丙型肝炎病毒抗原的特异性免疫球蛋白即抗体。一般在丙型肝炎患者的血清中其阳性率为80%左右或以下。抗-HCV阳性提示感染了丙型肝炎病毒；但亦存在较低的假阳性率。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条